Cleared Traditional

K230125 - Neuroblade System (FDA 510(k) Clearance)

Oct 2023
Decision
269d
Days
Class 2
Risk

K230125 is an FDA 510(k) clearance for the Neuroblade System. This device is classified as a Endoscope, Neurological (Class II - Special Controls, product code GWG).

Submitted by Clearmind Biomedical (Taipei, TW). The FDA issued a Cleared decision on October 13, 2023, 269 days after receiving the submission on January 17, 2023.

This device falls under the Neurology FDA review panel. Regulated under 21 CFR 882.1480. If The Device Is Reusable, Validated Reprocessing Instructions And Reprocessing Validation Data For This Device Type Must Be Included In A 510(k) Submission (82 Fr 26807, Available At Https://www.gpo.gov/fdsys/pkg/fr-2017-06-09/pdf/2017-12007.pdf)..

Submission Details

510(k) Number K230125 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received January 17, 2023
Decision Date October 13, 2023
Days to Decision 269 days
Submission Type Traditional
Review Panel Neurology (NE)
Summary Summary PDF

Device Classification

Product Code GWG - Endoscope, Neurological
Device Class Class II - Special Controls
CFR Regulation 21 CFR 882.1480
Definition If The Device Is Reusable, Validated Reprocessing Instructions And Reprocessing Validation Data For This Device Type Must Be Included In A 510(k) Submission (82 Fr 26807, Available At Https://www.gpo.gov/fdsys/pkg/fr-2017-06-09/pdf/2017-12007.pdf).